Barry Peters

2.1k total citations
50 papers, 1.3k citations indexed

About

Barry Peters is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Barry Peters has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 21 papers in Virology and 19 papers in Emergency Medicine. Recurrent topics in Barry Peters's work include HIV Research and Treatment (21 papers), HIV-related health complications and treatments (19 papers) and HIV/AIDS drug development and treatment (18 papers). Barry Peters is often cited by papers focused on HIV Research and Treatment (21 papers), HIV-related health complications and treatments (19 papers) and HIV/AIDS drug development and treatment (18 papers). Barry Peters collaborates with scholars based in United Kingdom, United States and Canada. Barry Peters's co-authors include Alastair Duncan, Jo Erwin, Louise M. Goff, Anthony S. Wierzbicki, Ranjababu Kulasegaram, A J Pinching, Janice Main, Thomas Lehner, Trevor Whittall and Andrew Hill and has published in prestigious journals such as The Lancet, PLoS ONE and Social Science & Medicine.

In The Last Decade

Barry Peters

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Peters United Kingdom 21 596 454 405 292 180 50 1.3k
Brygida Knysz Poland 19 1.2k 2.0× 707 1.6× 627 1.5× 787 2.7× 87 0.5× 105 2.2k
Clàudia Fortuny Spain 22 913 1.5× 410 0.9× 407 1.0× 627 2.1× 178 1.0× 118 1.6k
Laura Sighinolfi Italy 20 663 1.1× 445 1.0× 338 0.8× 329 1.1× 58 0.3× 56 1.2k
Eduardo Sprinz Brazil 26 1.5k 2.6× 968 2.1× 722 1.8× 503 1.7× 111 0.6× 92 2.2k
Barry S. Zingman United States 20 985 1.7× 438 1.0× 345 0.9× 652 2.2× 84 0.5× 57 1.6k
Melissa Krone United States 17 872 1.5× 862 1.9× 287 0.7× 566 1.9× 382 2.1× 25 1.7k
Marisa Montes Spain 20 906 1.5× 608 1.3× 395 1.0× 631 2.2× 49 0.3× 87 1.6k
Sarah Pett Australia 19 800 1.3× 724 1.6× 684 1.7× 569 1.9× 557 3.1× 59 2.0k
B Gazzard United Kingdom 22 647 1.1× 319 0.7× 220 0.5× 477 1.6× 148 0.8× 49 1.4k
Chris Taylor United Kingdom 17 549 0.9× 149 0.3× 237 0.6× 559 1.9× 72 0.4× 49 1.2k

Countries citing papers authored by Barry Peters

Since Specialization
Citations

This map shows the geographic impact of Barry Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Peters more than expected).

Fields of papers citing papers by Barry Peters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Peters. The network helps show where Barry Peters may publish in the future.

Co-authorship network of co-authors of Barry Peters

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Peters. A scholar is included among the top collaborators of Barry Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Peters. Barry Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rockstroh, Jürgen K., David M. Asmuth, Giuseppe Pantaleo, et al.. (2019). Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption. PLoS ONE. 14(1). e0210965–e0210965. 7 indexed citations
2.
Lachmann, Raskit, Sangmi Kim, Nishma Patel, et al.. (2015). A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection. AIDS. 29(10). 1127–1135. 21 indexed citations
3.
Peters, Barry, Anthony S. Wierzbicki, Lisa E. Wolber, et al.. (2013). A Cross-Sectional Randomised Study of Fracture Risk in People with HIV Infection in the Probono 1 Study. PLoS ONE. 8(10). e78048–e78048. 21 indexed citations
4.
Kozlakidis, Zisis, Christine Mant, Barry Peters, et al.. (2011). How Representative Are Research Tissue Biobanks of the Local Populations? Experience of the Infectious Diseases Biobank at King's College, London, UK. Biopreservation and Biobanking. 9(3). 287–288. 3 indexed citations
5.
Peters, Barry, Anthony S. Wierzbicki, Graeme Moyle, Devaki Nair, & Norbert H. Brockmeyer. (2011). The Effect of a 12-Week Course of Omega-3 Polyunsaturated Fatty Acids on Lipid Parameters in Hypertriglyceridemic Adult HIV-infected Patients Undergoing HAART: A Randomized, Placebo-Controlled Pilot Trial. Clinical Therapeutics. 34(1). 67–76. 23 indexed citations
6.
7.
Fox, Julie, et al.. (2010). Improvement in Vitamin D Deficiency Following Antiretroviral Regime Change: Results from the MONET Trial. AIDS Research and Human Retroviruses. 27(1). 29–34. 69 indexed citations
8.
Aboud, Michael, Ali Elgalib, Laura W. Pomeroy, et al.. (2010). Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study. International Journal of Clinical Practice. 64(9). 1252–1259. 45 indexed citations
9.
Kingsley, Cherry, Barry Peters, Kaboutar Babaahmady, et al.. (2009). Heterosexual and Homosexual Partners Practising Unprotected Sex May Develop Allogeneic Immunity and to a Lesser Extent Tolerance. PLoS ONE. 4(11). e7938–e7938. 11 indexed citations
10.
Read, Phillip, et al.. (2008). Disseminated gonococcal infection in a homosexual man diagnosed by nucleic acid amplification testing from a skin lesion swab. Sexually Transmitted Infections. 84(5). 348–349. 7 indexed citations
11.
Justesen, Ulrik Stenz, Zoë Fox, Court Pedersen, et al.. (2007). Pharmacokinetics of Two Randomized Trials Evaluating the Safety and Efficacy of Indinavir, Saquinavir and Lopinavir in Combination with Low‐Dose Ritonavir: The MaxCmin1 and 2 Trials*. Basic & Clinical Pharmacology & Toxicology. 101(5). 339–344. 6 indexed citations
12.
Whittall, Trevor, Yufei Wang, Justine Younson, et al.. (2006). Interaction between the CCR5 chemokine receptors and microbial HSP70. European Journal of Immunology. 36(9). 2304–2314. 53 indexed citations
13.
Peters, Barry, Trevor Whittall, Kaboutar Babaahmady, et al.. (2004). Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection. The Lancet. 363(9408). 518–524. 61 indexed citations
14.
Easterbrook, Philippa, Natalie Ives, Anele Waters, et al.. (2002). The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml. AIDS. 16(11). 1521–1527. 55 indexed citations
15.
Saul, Jacky, et al.. (2001). The Relationships between Ethnicity, Sex, Risk Group, and Virus Load in Human Immunodeficiency Virus Type 1 Antiretroviral‐Naive Patients. The Journal of Infectious Diseases. 183(10). 1518–1521. 16 indexed citations
16.
Erwin, Jo & Barry Peters. (1999). Treatment issues for HIV+ Africans in London. Social Science & Medicine. 49(11). 1519–1528. 63 indexed citations
17.
Erwin, Jo & Barry Peters. (1998). The critical relationship between compliance and the management of infectious diseases. Clinical Microbiology and Infection. 4(5). 275–279. 7 indexed citations
18.
Peters, Barry, et al.. (1997). A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects. Journal of Infection. 35(3). 231–235. 41 indexed citations
19.
Peters, Barry, et al.. (1994). Adverse Effects of Drugs Used in the Management of Opportunistic Infections Associated with HIV Infection. Drug Safety. 10(6). 439–454. 18 indexed citations
20.
Gompels, Mark, Andrew Hill, Paul Jenkins, et al.. (1992). Kaposiʼs sarcoma in HIV infection treated with vincristine and bleomycin. AIDS. 6(10). 1175–1180. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brygida Knysz Breakdown of academic impact, for papers by Clàudia Fortuny Breakdown of academic impact, for papers by Laura Sighinolfi Breakdown of academic impact, for papers by Eduardo Sprinz Breakdown of academic impact, for papers by Barry S. Zingman Breakdown of academic impact, for papers by Melissa Krone Breakdown of academic impact, for papers by Marisa Montes Breakdown of academic impact, for papers by Sarah Pett Breakdown of academic impact, for papers by B Gazzard Breakdown of academic impact, for papers by Chris Taylor
Rankless by CCL
2026